Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Infections × Other × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Plasma cell 5 Gynecologic 5 Myeloid 4 Lymphoid 4 Dermatologic 3 Other neoplasm 2 Genitourinary 2 CNS 2 Breast 2 Sarcoma 1 Other 1 Classical hematology 1

Conditions

Mucositis 38 Obesity 22 Neoplasms 17 Head and Neck Neoplasms 13 Dyspnea 12 Stomatitis 10 Constipation 9 Squamous Cell Carcinoma of Head and Neck 7 Sexual Dysfunction, Physiological 6 Overweight 6 Breast Neoplasms 6 Xerostomia 5 Radiation Injuries 4 Opioid-Induced Constipation 4 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Nausea 3 Mouth Neoplasms 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Polycystic Ovary Syndrome 2 Pain 2 Multiple Myeloma 2 Leukemia 2 Intestinal Diseases 2 Febrile Neutropenia 2 Endometrial Neoplasms 2 Endometrial Hyperplasia 2

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡